Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by doctordeaconon Jan 31, 2017 6:39pm

79 Views

Post# 25780397

RE:RE:canopy and newfarms is there a connection

momentum get back in your workstation cubicle next to bill and beside judy and pull out your ham sandwitch out of your cosco lunchbox and read the posts from now on and watch your 1k investment in NF make you 2k and then you can complete your high roller lifestyle with a new fridge from sears ,lol.

Bullboard Posts

Debt-free cannabis company set for next stage of growth